½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1509493

½ÉÆó ¹ÙÀÌÆнº Àåºñ ½ÃÀå : Á¦Ç° À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°

Cardiopulmonary Bypass Equipment Market, By Product Type, By End User, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

½ÉÆó ¹ÙÀÌÆнº Àåºñ ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â 2¾ï 510¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2024-2031³â CAGRÀº 2.6%·Î 2031³â¿¡´Â 2¾ï 4,620¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

±×¸² 1. ½ÉÆó ¹ÙÀÌÆнº Àåºñ ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2024³â
Cardiopulmonary Bypass Equipment Market-IMG1

½ÉÆó ¹ÙÀÌÆнº Àåºñ´Â ½ÉÀå ¼ö¼ú Áß Ç÷¾×¿¡ »ê¼Ò¸¦ °ø±ÞÇØ Ã¼¿Ü·Î ¼øȯ½ÃÅ°´Â ÀåºñÀÔ´Ï´Ù. ½ÉÆó ¹ÙÀÌÆнº Àåºñ ¼¼°è ½ÃÀåÀº ½ÉÇ÷°ü Áúȯ ȯÀÚ Áõ°¡¿Í ÃÖ¼Òħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î Áö³­ ¸î ³â µ¿¾È ¼ºÀå¼¼¸¦ º¸ÀÌ°í ÀÖ½À´Ï´Ù. ½ÉÆó ¹ÙÀÌÆнº´Â °³½É¼ú°ú °°Àº ¼ö¼ú Áß ½ÉÀå°ú ÆóÀÇ ±â´ÉÀ» ÀϽÃÀûÀ¸·Î ´ë½ÅÇÒ ¼ö ÀÖ½À´Ï´Ù. À̸¦ ÅëÇØ ¿Ü°úÀÇ»ç´Â ȯÀÚÀÇ Ç÷¾×À» ÆßÇÎÇÏ°í »ê¼Ò¸¦ °ø±ÞÇÏ°í ¼øȯÀ» µÇµ¹¸®¸é¼­ Á¤ÁöµÈ ½ÉÀåÀ¸·Î ÀÛ¾÷ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¾ÈÀü, È¿À²¼º, Á¤¹Ð¼ºÀ» À§ÇÑ Çâ»óµÈ ±â¼úÀ» °®Ãá ½ÉÆó ¹ÙÀÌÆнº ½Ã½ºÅÛÀÇ ¹ßÀüÀ¸·Î º¹ÀâÇÑ ¼ö¼úÀÌ ¿ëÀÌÇØÁö°í ½ÃÀå ¼ºÀåÀ» ÁÖµµÇÏ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ:

¼¼°è ½ÉÆó ¹ÙÀÌÆнº Àåºñ ½ÃÀåÀÇ ¼ºÀåÀº °Ç°­¿¡ ÇØ·Î¿î »ýÈ° ½À°üÀ¸·Î ÀÎÇÑ ¼¼°è ½ÉÇ÷°ü Áúȯ À¯º´·ü Áõ°¡¿Í ³ëÀÎ Àα¸ Áõ°¡ µîÀÇ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖÀ¸¸ç, ¼¼°èº¸°Ç±â±¸(WHO)°¡ ¹ßÇ¥ÇÑ µ¥ÀÌÅÍ¿¡ µû¸£¸é ½ÉÇ÷°ü Áúȯ ¶Ç´Â CVD´Â Àü ¼¼°è ÁÖ¿ä »ç¸Á ¿øÀÎÀ¸·Î ¸Å³â ¾à 1,790¸¸ ¸íÀÌ CVD·Î ÀÎÇØ »ç¸ÁÇÏ´Â °ÍÀ¸·Î ÃßÁ¤µÇ°í ÀÖ½À´Ï´Ù. ÃÖ¼Òħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í ¼ö¼ú À§Çè, ¿Ü»ó ¹× ȸº¹ ½Ã°£À» ÁÙÀÌ´Â Á¦Ç° Çõ½ÅÀÌ °áÇÕµÇ¾î ½ÉÆó ¹ÙÀÌÆнº ½Ã½ºÅÛÀÇ Ã¤ÅÃÀ» ÃËÁøÇÏ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ¹ÙÀÌÆнº Àåºñ ¹× ¼ö¼ú°ú °ü·ÃµÈ ³ôÀº ºñ¿ëÀÌ ½ÃÀå ¼ºÀå¿¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ¹Ý¸é, ½ÅÈï±¹¿¡¼­´Â ÀÇ·á °ü±¤ÀÇ Áõ°¡¿Í ÀÇ·á ÀÎÇÁ¶ó ¼­ºñ½º °³¼±ÀÌ ½ÃÀå ¼ºÀåÀÇ ±âȸ·Î ÀÛ¿ëÇÏ°í ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Ư¡

  • ÀÌ Á¶»ç º¸°í¼­´Â 2023³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2024-2031³â)ÀÇ ½ÃÀå ±Ô¸ð¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR%)¿¡ ´ëÇÑ ¼¼°è ½ÉÆó ¹ÙÀÌÆнº Àåºñ ½ÃÀåÀ» »ó¼¼È÷ ºÐ¼®ÇÕ´Ï´Ù.
  • ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ÆľÇÇÏ°í ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­´Â ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ¼º°ú, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ½ÉÆó ¹ÙÀÌÆнº Àåºñ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ °³¿äÀ» Á¦°øÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆà ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ­, ½ÃÀå È®´ë ¹× ¸¶ÄÉÆà Àü¼ú¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
  • ½ÉÆó ¹ÙÀÌÆнº Àåºñ ¼¼°è ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë ¾÷ü, ½Å±Ô ÁøÀÔÀÚ, À繫 ºÐ¼®°¡ µî ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ °ü°èÀÚ¸¦ ´ë»óÀ¸·ÎÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ½ÉÆó ¹ÙÀÌÆнº Àåºñ ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ½±°Ô ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú °¡Á¤

  • Á¶»ç ¸ñÀû
  • °¡Á¤
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
  • ¿µÇ⠺м®
  • ½ÃÀå µ¿Çâ
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Àμö¿Í Á¦ÈÞ ½Ã³ª¸®¿À
  • ÀÚ±Ý Á¶´Þ°ú ÅõÀÚ
  • PEST ºÐ¼®
  • Porters ºÐ¼®

Á¦4Àå ¼¼°èÀÇ ½ÉÆó ¹ÙÀÌÆнº Àåºñ ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • ÀüüÀûÀÎ ¿µÇâ
  • Á¤ºÎ À̴ϼÅƼºê
  • COVID-19ÀÇ ½ÃÀå¿¡ ´ëÇÑ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ½ÉÆó ¹ÙÀÌÆнº Àåºñ ½ÃÀå, Á¦Ç° À¯Çüº°, 2019-2031³â(100¸¸ ´Þ·¯)

  • ¼Ò°³
  • ½Ì±Û ·Ñ·¯ ÆßÇÁ
  • ´õºí ·Ñ·¯ ÆßÇÁ

Á¦6Àå ¼¼°èÀÇ ½ÉÆó ¹ÙÀÌÆнº Àåºñ ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2031³â(100¸¸ ´Þ·¯)

  • ¼Ò°³
  • º´¿ø
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ ½ÉÆó ¹ÙÀÌÆнº Àåºñ ½ÃÀå, Áö¿ªº°, 2019-2031³â(100¸¸ ´Þ·¯)

  • ¼Ò°³
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿

Á¦8Àå °æÀï »óȲ

  • ±â¾÷ °³¿ä
    • Medtronic
    • LivaNova
    • Terumo Cardiovascular Systems Corporation
    • Maquet Holding BV &Co. KG
    • Braun Melsungen AG
    • Medica spa
    • Eurosets
    • Fresenius Medical Care AG &Co. KGaA
    • Lepu Medical Technology
    • Elite Life Care
    • OriGen Biomedical
    • Tianjin Medical
    • Soma Technology, Inc.
    • Braile Biomedica
    • CardioGenesis Corporation
    • Century Medical, Inc.
    • Nonin Medical, Inc.
    • Xijian Medical

Á¦9Àå ¾Ö³Î¸®½ºÆ®ÀÇ Ãßõ»çÇ×

  • Wheel of Fortune
  • Coherent Opportunity Map

Á¦10Àå Âü°í¹®Çå°ú Á¶»ç ¹æ¹ý

  • Âü°í¹®Çå
  • Á¶»ç ¹æ¹ý
ksm 24.07.15

Global cardiopulmonary bypass equipment market is estimated to be valued at US$ 205.1 Mn in 2024 and is expected to reach USD 246.2 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 2.6 % from 2024 to 2031.

Figure 1. Cardiopulmonary Bypass Equipment Market Share (%), By Region, 2024
Cardiopulmonary Bypass Equipment Market - IMG1

Cardiopulmonary bypass equipment are devices that are used to oxygenate and circulate blood outside the body during cardiac surgery. Global cardiopulmonary bypass equipment market has been witnessing growth over the past few years due to rising cases of cardiovascular diseases and rising demand for minimally invasive surgical procedures. Cardiopulmonary bypass allows temporary takeover of heart and lung functions during procedures such as open-heart surgery. It enables surgeons to work on a still heart while the patient's blood is pumped, oxygenated, and returned to circulation. Advancements in cardiopulmonary

y bypass systems with improved technology for safety, efficiency, and precision have been facilitating complex surgeries and driving the market growth.

Market Dynamics:

Global cardiopulmonary bypass equipment market growth is driven by factors like rising prevalence of cardiovascular diseases globally due to unhealthy lifestyle habits and growing geriatric population. According to the data published by WHO, cardiovascular diseases or CVDs are a major cause of mortality worldwide, with an estimated 17.9 million people die due to CVDs each year. Increasing demand for minimally invasive procedures coupled with product innovations to reduce surgical risk, trauma, and recovery time can boost adoption of cardiopulmonary bypass systems. However, high costs associated with bypass equipment and surgeries can hamper the market growth. Meanwhile, emerging economies along with growing medical tourism and improving healthcare infrastructure and services can offer market growth opportunities.

Key Features of the Study:

  • This report provides in-depth analysis of the global cardiopulmonary bypass equipment market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global cardiopulmonary bypass equipment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Medtronic, Sorin Group, Terumo Corporation, MAQUET, Braile Biomedica, and Tianjin Medical
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global cardiopulmonary bypass equipment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cardiopulmonary bypass equipment market

Detailed Segmentation-

  • By Product Type
    • Single Roller Pump
    • Double Roller Pump
  • By End User
    • Hospitals
    • Ambulatory Surgical Centres
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Medtronic
    • LivaNova
    • Terumo Cardiovascular Systems Corporation
    • Maquet Holding BV & Co. KG
    • Braun Melsungen AG
    • Medica s.p.a.
    • Eurosets
    • Fresenius Medical Care AG & Co. KGaA
    • Lepu Medical Technology
    • Elite Life Care
    • OriGen Biomedical
    • Tianjin Medical
    • Soma Technology, Inc.
    • Braile Biomedica
    • CardioGenesis Corporation (part of Philips)
    • Century Medical, Inc.
    • Nonin Medical, Inc.
    • Xijian Medical

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Cardiopulmonary Bypass Equipment Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Cardiopulmonary Bypass Equipment Market, By Product Type, 2019 - 2031, (USD Mn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Single Roller Pump
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Double Roller Pump
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global Cardiopulmonary Bypass Equipment Market, By End User, 2019 - 2031, (USD Mn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Hospitals
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Ambulatory Surgical Centres
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global Cardiopulmonary Bypass Equipment Market, By Region, 2019 - 2031, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
      • GCC
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Mn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Company Profiles
    • Medtronic
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • LivaNova
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Terumo Cardiovascular Systems Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Maquet Holding BV & Co. KG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Braun Melsungen AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Medica s.p.a.
    • Eurosets
    • Fresenius Medical Care AG & Co. KGaA
    • Lepu Medical Technology
    • Elite Life Care
    • OriGen Biomedical
    • Tianjin Medical
    • Soma Technology, Inc.
    • Braile Biomedica
    • CardioGenesis Corporation
    • Century Medical, Inc.
    • Nonin Medical, Inc.
    • Xijian Medical

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦